VISTAGEN THERAPEUTICS, INC. Warrant To Purchase Common StockVistaGen Therapeutics, Inc. • December 7th, 2017 • Pharmaceutical preparations • New York
VistaGen Therapeutics, Inc., a company organized under the laws of Nevada (the "Company"), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [HOLDER], the registered holder hereof or its permitted assigns (the "Holder"), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the Issuance Date (the “Initial Exercisability Date”), but not after 11:59 p.m., New York time, on the Expiration Date, (as defined below), ______________ (_____________)1 fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the "Warrant Shares"). Except as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this "Warrant"), shall have the me
VistaGen Therapeutics, Inc. [_] Shares of Common Stock [_] Warrants to Purchase up to [_] Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • December 7th, 2017 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • New York
VistaGen Therapeutics, Inc., a Nevada corporation (the "Company") proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule I to this Agreement (the "Underwriters"), for whom you are acting as Representative (the “Representative”), an aggregate of (i) [_] shares (the "Shares") of the Company's common stock, $0.001 par value per share (the "Common Stock"), and (ii) warrants (the “Warrants”) to purchase up to an aggregate of [_] shares of Common Stock (the “Warrant Shares”). Each Share is being sold together with 1.0 Warrant to purchase one Warrant Share. The Shares, the Warrants and the Warrant Shares are collectively referred to as the “Securities”. The Shares and the Warrants will be issued separately, but will be purchased together in the offering. The respective amounts of the Securities to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto.
